Blood-brain barrier transport of a novel μ1-specific opioid peptide, H-Tyr-D-Arg-Phe-β-Ala-OH (TAPA)

Journal of Neurochemistry

Volumn 84, Issue 5, 2003, Pages 1154-1161

  Deguchi, Yoshiharu ^a   Miyakawa, Yusaku ^b   Sakurada, Shinobu ^c   Naito, Yu ^b   Morimoto, Kazuhiro ^b   Ohtsuki, Sumio ^d   Hosoya, Ken ichi ^e   Terasaki, Tetsuya ^d  

^a TEIKYO UNIVERSITY   (Japan)

^b HOKKAIDO INSTITUTE OF TECHNOLOGY   (Japan)

^c TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

^d TOHOKU UNIVERSITY   (Japan)

^e UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Adsorptive mediated endocytosis; Blood brain barrier; Dermorphin analog; Immortalized cell line; Peptide transport system

Indexed keywords

2,4 DINITROPHENOL; DANSYLCADAVERINE; DERMORPHIN DERIVATIVE; MU OPIATE RECEPTOR; POLYLYSINE; PROTAMINE; TYROSYL DEXTRO ARGINYLPHENYLALANYL BETA ALANINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; CAPILLARY ENDOTHELIUM; CONTROLLED STUDY; DRUG TRANSPORT; ENDOCYTOSIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN TRANSPORT;

2,4-DINITROPHENOL; ANIMALS; BINDING, COMPETITIVE; BLOOD-BRAIN BARRIER; BRAIN; CADAVERINE; CAPILLARIES; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENDOCYTOSIS; ENDOTHELIUM, VASCULAR; HYDROGEN-ION CONCENTRATION; IODINE RADIOISOTOPES; MICE; MICE, INBRED STRAINS; OLIGOPEPTIDES; PERMEABILITY; POLYAMINES; POLYMERS; RECEPTORS, OPIOID, MU; TEMPERATURE;

ANIMALIA;

EID: 0037341140     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.01582.x     Document Type: Article

References (27)

1. Bickel U., Yoshikawa T. and Pardridge W. M. (2001) Delivery of peptides and proteins through the blood-brain barrier. Adv. Drug Deliv. Rev. 46, 247-279.
2. Boado R. J., Li J. Y., Nagaya M., Zhang C. and Pardridge W. M. (1999) Selective expression of the large neutral amino acid transporter (LAT) at the blood-brain barrier. Proc. Natl Acad. Sci. USA 96, 12079-12084.
3. 4]-dermorphin tetrapeptide; physical dependence liability in mice. Neuropeptide 13, 83-88.
4. Chaki K., Sakurada S., Sakurada T., Kensuke K. and Suzuki K. (1990) N-Terminal tetrapeptide of dermorphin and D-Arg-substituted tetrapeptides: inactivation process of the antinociceptive activity by peptidase. Life Sci. 46, 1671-1678.
5. Dagenais C., Ducharme J. and Pollack G. M. (2001) Uptake and efflux of the peptidic delta-opioid receptor agonist. Neurosci. Lett. 301, 155-158.
6. Deguchi Y., Inabe K., Tomiyasu K., Nozawa K., Yamada S. and Kimura R. (1995) Study on brain interstitial fluid distribution and blood brain barrier transport of baclofen in rats by microdialysis. Pharm. Res. 12, 1838-1844.
7. 125I-labeled basic fibroblast growth factor. Pharm. Res. 17, 63-69.
8. Deguchi Y., Okutsu H., Okura T., Yamada S., Kimura R., Yuge T., Furukawa A., Morimoto K., Tachikawa M., Ohtsuki S. et al. (2002) Internalization of basic fibroblast growth factor at the mouse blood brain barrier involves perlecan, a heparan sulfate proteoglycan. J. Neurochem. 83, 381-389.
9. Fiori A., Cardelli P., Negri L., Savi M. R., Strom R. and Erspamer V. (1997) Deltorphin transport across the blood-brain barrier. Proc. Natl Acad. Sci. USA 94, 9469-9474.
10. Golden P. L., Maccagnan T. J. and Pardridge W. M. (1997) Human blood-brain barrier leptin receptor. Binding and endocytosis in insolated human brain microvessels. J. Clin. Invest. 99, 14-18.
11. Hosoya K., Tetsuka K., Nagase K., Tomi M., Saeki S., Ohtsuki S., Takanaga H., Yanai N., Obinata M., Kikuchi A. et al. (2000) Conditionally immortalized brain capillary endothelial cell lines established from a transgenic mouse harboring temperature sensitive simian virus 40 large T-antigen gene. AAPS Pharmsci. 2, article 27 available at http://www.pharmsci.org/.
12. Kastin A. J., Pan W., Maness L. M. and Banks W. A. (1999) Peptides crossing the blood-brain barrier: some unusual observations. Brain Res. 848, 96-100.
13. King M., Su W., Chang A., Zuckerman A. and Pasternak G. W. (2001) Transport of opioids from the brain to the periphery by P-glycoprotein: peripheral actions of central drugs. Nature Neurosci. 4, 268-274.
14. Narita M., Funada M. and Suzuki T. (2001) Regulations of opioid dependence by opioid receptor types. Pharmacol. Ther. 89, 1-15.
15. Pardridge W. M. (1999) Vector-mediated drug delivery to the brain. Adv. Drug Deliv. Rev. 36, 299-321.
16. Pasternak G. W. (2001) Insights into mu opioid pharmacology the role of mu opioid receptor subtypes. Life Sci. 68, 2213-2219.
17. Ray E. and Samanta K. (1996) Dansylcadaverine regulates ligand induced endocytosis of interleukin-8 receptor in human polymorphonuclear neutrophils. FEBS Lett. 378, 235-239.
18. Rose J. M. and Audus K. L. (1998) Receptor-mediated angiotensin II transcytosis by brain microvessel endothelial cells. Peptides 19, 1023-1030.
19. Rousselle C., Smirnova M., Clair P., Lefauconnier J. M., Chavanieu A., Calas B., Scherrmann J. M. and Temsamani J. (2001) Enhanced delivery of doxorubicin into the brain via a peptide-vector-mediated strategy: saturation kinetics and specificity. J. Pharmacol. Exp. Ther. 296, 124-131.
20. Sakurada S., Takeda S., Sato T., Hayashi T., Yuki M., Kutsuwa M., Tan-No K., Sakurada C., Kisara K. and Sakurada T. (2000) Selective antagonism by naloxonazine of antinociception by Tyr-DArg-Phe-β-Ala, a novel dermorphin analogue with high affinity at mu-opioid receptors. Eur. J. Pharmacol. 395, 107-112.
21. Samii A., Bickel U., Stroth U. and Pardridge W. (1994) Blood-brain barrier transport of neuropeptides: analysis with a metabolically stable dermorphin analogue. Am. J. Physiol. 267, E124-E131.
22. 2substituted tetrapeptides. J. Pharmacol. Exp. Ther. 242, 654-659.
23. Tamai I., Sai Y., Kobayashi H., Kamata M., Wakamiya T. and Tsuji A. (1997) Structure-internalization relationship for adsorptivemediated endocytosis of basic peptides at the blood-brain barrier. J. Pharmacol. Exp. Ther. 280, 410-415.
24. Tanabe S., Shimohigashi Y., Nakayama Y., Makino T., Fujita T., Nose T., Tsujimoto G., Yokokura T., Naito M., Tsuruo T. et al. (1999) In vivo and in vitro evidence of blood-brain barrier transport of a novel cationic arginine-vasopressin fragment 4-9 analog. J. Pharmacol. Exp. Ther. 290, 561-568.
25. Terasaki T., Deguchi Y., Sato H., Hirai K. and Tsuji A. (1991) In vivo transport of a dynorphin-like analgesic peptide, E-2078, through the blood-brain barrier: An application of brain microdialysis. Pharm. Res. 8, 815-820.
26. Yamaoka K., Tanigawara Y., Nakagawa T. and Uno T. (1980) Pharmacokinetic analysis program (MULTI) for microcomputer. J. Pharmcobio-Dyn. 4, 879-885.
27. Zlokovic B. V., Martel C. L., Matsubara E., McComb J. G., Zheng G., McCluskey R. T., Frangione B. and Ghiso J. (1996) Glycoprotein 330/megalin: Probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid β at the blood-brain and blood-cerebrospinal fluid barriers. Proc. Natl Acad. Sci. USA 93, 4229-4234.